Zogenix expects little fall-out from end of Astellas tie-up for Sumavel
23 December 2011
Ian Haydock
Please Login to read the full article.
23 December 2011
Ian Haydock
ian.haydock@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Zogenix, Duract in deal for work on once-monthly risperidone, to contrast with J&J blockbuster
- Zogenix's long-acting hydrocodone meets chronic pain endpoint, ready for 2012 filing
- Zogenix adds $60 million equity to take lead to NDA and fund operations until 2013
- Pozen migraine drug licensed to Desitin for commercialisation in Europe
ANALYSIS
Other Informa Analysis
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
